Cloning and pharmacological characterization of a rat μ opioid receptor

We have isolated a rat cDNA clone that displays 75% amino acid homology with the mouse delta and rat kappa opioid receptors. The cDNA (designated pRMuR-12) encodes a protein of 398 amino acids comprising, in part, seven hydrophobic domains similar to those described for other G protein-linked receptors. Data from binding assays conducted with COS-1 cells transiently transfected with a CMV mammalian expression vector containing the full coding region of pRMuR-12 demonstrated mu receptor selectivity. In situ hybridization mRNA analysis revealed an mRNA distribution in rat brain that corresponds well to the distribution of binding sites labeled with mu-selective ligands. Based upon these observations, we conclude that pRMuR-12 encodes a mu opioid receptor.

[1]  A. Goldstein,et al.  Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. , 1984, Molecular pharmacology.

[2]  P. Wood.  The significance of multiple CNS opioid receptor types: A review of critical considerations relating to technical details and anatomy in the study of central opioid actions , 1988, Peptides.

[3]  T. Cicero,et al.  Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes. , 1988, European journal of pharmacology.

[4]  P. Seeburg,et al.  Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. , 1989, The EMBO journal.

[5]  B. Cox,et al.  Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. , 1988, Molecular pharmacology.

[6]  G. Koski,et al.  Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Zukin,et al.  Neuroanatomical localization ofκ 1and κ 2 opioid receptors in rat and guinea pig brain , 1991, Brain Research.

[8]  R. Zukin,et al.  Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain. , 1983, Molecular pharmacology.

[9]  F. Medzihradsky,et al.  Receptor-mediated stimulation of brain GTPase by opiates in normal and dependent rats. , 1984, Biochemical and biophysical research communications.

[10]  R. Zerbe,et al.  Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  R. Zukin,et al.  Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Wikler.  Opioid Receptors and Endogenous Opioid Peptides , 1980 .

[14]  R. Zukin,et al.  Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[16]  G. Koski,et al.  Solubilization of active opiate receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Pasternak,et al.  Classification of multiple morphine and enkephalin binding sites in the central nervous system. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Besse,et al.  Autoradiographic distribution of μ, δ and κ opioid binding sites in the superficial dorsal horn, over the rostrocaudal axis of the rat spinal cord , 1991, Brain Research.

[19]  M. Herkenham,et al.  Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824 , 1987, Peptides.

[20]  H. Loh,et al.  Purification to apparent homogeneity of a mu-type opioid receptor from rat brain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.

[22]  H. Akil,et al.  Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain A. Mansour H. Khachaturian, M.E. Lewis, H. Akil and S.J. Watson, Neuroscience, 7 (1987) 2445–2464 , 1988, Pain.

[23]  J. Besson,et al.  Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord , 1990, Brain Research.

[24]  M. Herkenham,et al.  Autoradiographic localization of mu- and delta-opiate receptors in the forebrain of the rat. , 1986, Brain research.

[25]  G. Pasternak.  Pharmacological mechanisms of opioid analgesics. , 1993, Clinical neuropharmacology.

[26]  G. Pasternak,et al.  Minireview: Multiple MU opiate receptors , 1986 .

[27]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[28]  A Goldstein,et al.  Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Strader,et al.  Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase. , 1989, Molecular pharmacology.

[30]  A. Goldstein,et al.  Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Loh,et al.  Solubilization of membrane bound opiate receptor from rat brain. , 1981, Life sciences.

[32]  R. Zukin,et al.  Neuroanatomical localization of kappa 1 and kappa 2 opioid receptors in rat and guinea pig brain. , 1991, Brain research.

[33]  E. J. Simon,et al.  Solubilization of a stereospecific opiate-macromolecular complex from rat brain , 1975, Science.

[34]  H. Ueda,et al.  Purified opioid μ-receptor is of a different molecular size than δ- and κ-receptors , 1987, Neuroscience Letters.

[35]  P. Roche,et al.  Identification of hormone-binding regions of the luteinizing hormone/human chorionic gonadotropin receptor using synthetic peptides. , 1992, Endocrinology.

[36]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[37]  E. Hewlett,et al.  ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. , 1984, The Journal of biological chemistry.

[38]  A. Goldstein,et al.  Multiple opioid receptors: ligand selectivity profiles and binding site signatures. , 1989, Molecular pharmacology.

[39]  E. J. Simon,et al.  Solubilization of an active opiate receptor from Bufo marinus. , 1980, European journal of pharmacology.

[40]  B. Attali,et al.  K‐Opiate Agonists Inhibit Adenylate Cyclase and Produce Heterologous Desensitization in Rat Spinal Cord , 1989 .

[41]  P. Wood.  Multiple opiate receptors: Support for unique mu, delta and kappa sites , 1982, Neuropharmacology.

[42]  J. Woods,et al.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. , 1981, Life sciences.

[43]  Lei Yu,et al.  Molecular cloning and functional expression of a mu opioid receptor from rat brain , 1994, Regulatory Peptides.

[44]  S. Watson,et al.  Anatomical Distribution of Opioid Receptors in Mammalians: An Overview , 1993 .

[45]  E. J. Simon,et al.  Solubilization and characterization of active opiate binding sites from mammalian brain. , 1982, The Journal of pharmacology and experimental therapeutics.

[46]  T. Cicero,et al.  Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for κ opioid receptor subtypes , 1988 .

[47]  G. Bell,et al.  Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Sprengel,et al.  Amino‐terminal leucine‐rich repeats in gonadotropin receptors determine hormone selectivity. , 1991, The EMBO journal.

[49]  E. Barnard,et al.  Solubilization in high yield of opioid receptors retaining high‐affinity delta, mu and kappa binding sites , 1984, FEBS letters.

[50]  W. Martin,et al.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[51]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[52]  D. Segaloff,et al.  Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. , 1990, The Journal of biological chemistry.

[53]  S. Snyder,et al.  Identification of novel high affinity opiate receptor binding in rat brain , 1975, Nature.

[54]  H. Kim,et al.  Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. , 1986, Life sciences.

[55]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  H. Kosterlitz,et al.  SPECTRUM OF THE μ‐, δ‐ AND κ‐BINDING SITES IN HOMOGENATES OF RAT BRAIN , 1982 .

[57]  J. Morley,et al.  Involvement of dynorphin and the kappa opioid receptor in feeding , 1983, Peptides.

[58]  R. A. Lutz,et al.  Opioid receptors and their pharmacological profiles. , 1992, Journal of receptor research.

[59]  J. Bidlack,et al.  Solubilization of the opiate receptor. , 1980, Life sciences.

[60]  A. Goldstein,et al.  Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity. , 1984, Molecular pharmacology.